We are international
Donate
TEXT SIZE   


ASH 2012: Dr. Cavo - Impact of Bortezomib Incorporated Into Autotransplantation On Outcomes of Myeloma Patients with High-Risk Cytogenetics: An Integrated Analysis of 1894 Patients Enrolled in Four European Phase 3 Studies
Michele Cavo, MD
Bologna University School of Medicine
Bologna, Italy
12.02.12


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles